When patient centricity is applied only once a product comes to market, subtler influencers of adherence could be missed, say William Hind of Alpharmaxim and Lisa Campbell of SSI Strategy For drug development to be truly patient focused, patient considerations need to be incorporated right from the earliest stages of drug discovery and development.  These … Continue reading Patient-focused drug development: applying behavioral science from day one to understand patients’ real priorities